Drugs / Respirogen Micro-Oxygen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04870801 | Jan 2022 → Jan 2024 | — | Christopher Bell | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Respirogen Micro-Oxygen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04870801 ↗ |
| Route | Rectal | “Enteral (rectal) delivery of Respirogen Micro-Oxygen” NCT04870801 ↗ |